Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Morphologic and GATA1 sequencing analysis of hematopoiesis in fetuses with trisomy 21.

Hoeller S, Bihl MP, Tzankov A, Chaffard R, Hirschmann P, Miny P, Kühne T, Bruder E.

Hum Pathol. 2014 May;45(5):1003-9. doi: 10.1016/j.humpath.2013.12.014. Epub 2014 Jan 17.

PMID:
24746204
2.

Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21.

Rainis L, Bercovich D, Strehl S, Teigler-Schlegel A, Stark B, Trka J, Amariglio N, Biondi A, Muler I, Rechavi G, Kempski H, Haas OA, Izraeli S.

Blood. 2003 Aug 1;102(3):981-6. Epub 2003 Mar 20.

3.

Are GATA1 mutations occurring at random in Down syndrome transient leukemia?

Satgé D.

Med Hypotheses. 2014 Aug;83(2):154-9. doi: 10.1016/j.mehy.2014.05.005. Epub 2014 May 20.

PMID:
24880866
4.

Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations.

Tunstall-Pedoe O, Roy A, Karadimitris A, de la Fuente J, Fisk NM, Bennett P, Norton A, Vyas P, Roberts I.

Blood. 2008 Dec 1;112(12):4507-11. doi: 10.1182/blood-2008-04-152967. Epub 2008 Aug 8.

5.

Trisomy 21 enhances human fetal erythro-megakaryocytic development.

Chou ST, Opalinska JB, Yao Y, Fernandes MA, Kalota A, Brooks JS, Choi JK, Gewirtz AM, Danet-Desnoyers GA, Nemiroff RL, Weiss MJ.

Blood. 2008 Dec 1;112(12):4503-6. doi: 10.1182/blood-2008-05-157859. Epub 2008 Sep 23.

6.

Down myeloid disorders: a paradigm for childhood preleukaemia and leukaemia and insights into normal megakaryopoiesis.

Vyas P, Roberts I.

Early Hum Dev. 2006 Dec;82(12):767-73. Epub 2006 Oct 24. Review.

PMID:
17064858
7.

[GATA1-mutation associated leukemia in children with trisomy 21 mosaic].

Reinhardt D, Reinhardt K, Neuhoff C, Sander A, Klusmann JH, Pekrun A, Sauerbrey A, von Stackelberg A, Rössig C, Creutzig U, Kolenova A.

Klin Padiatr. 2012 Apr;224(3):153-5. doi: 10.1055/s-0032-1308988. Epub 2012 Apr 18. German.

PMID:
22513796
8.

Induction of hyperproliferative fetal megakaryopoiesis by an N-terminally truncated GATA1 mutant.

Shimizu R, Kobayashi E, Engel JD, Yamamoto M.

Genes Cells. 2009 Sep;14(9):1119-31. doi: 10.1111/j.1365-2443.2009.01338.x. Epub 2009 Aug 13.

9.

Risk for leukemia in infants without Down syndrome who have transient myeloproliferative disorder.

Cushing T, Clericuzio CL, Wilson CS, Taub JW, Ge Y, Reichard KK, Winter SS.

J Pediatr. 2006 May;148(5):687-9.

PMID:
16737888
10.

The impact of trisomy 21 on early human hematopoiesis.

Roy A, Cowan G, Vyas P, Roberts I.

Cell Cycle. 2013 Feb 15;12(4):533-4. doi: 10.4161/cc.23667. Epub 2013 Jan 23. No abstract available.

11.

Molecular insights into Down syndrome-associated leukemia.

Vyas P, Crispino JD.

Curr Opin Pediatr. 2007 Feb;19(1):9-14. Review.

PMID:
17224656
12.

Severe TMD/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome.

Heald B, Hilden JM, Zbuk K, Norton A, Vyas P, Theil KS, Eng C.

Nat Clin Pract Oncol. 2007 Jul;4(7):433-8.

PMID:
17597708
13.

[GATA1 analysis in myeloproliferative disorders associated to trisomy 21].

Fuster Soler JL, Norton A, Galera Miñarro A, Bermúdez Cortés M, Llinares Riestra ME, Ortuño Giner F.

An Pediatr (Barc). 2011 Jan;74(1):31-7. doi: 10.1016/j.anpedi.2010.08.012. Epub 2010 Sep 25. Spanish.

14.

GATA1 mutation and trisomy 21 are required only in haematopoietic cells for development of transient myeloproliferative disorder.

Carpenter E, Valverde-Garduno V, Sternberg A, Mitchell C, Roberts I, Vyas P, Vora A.

Br J Haematol. 2005 Feb;128(4):548-51.

PMID:
15686466
15.

[The role of GATA1 mutation in acute megakaryocytic leukemia].

Ito E.

Rinsho Ketsueki. 2006 Nov;47(11):1415-22. Review. Japanese. No abstract available.

PMID:
17176883
16.

Contribution of GATA1 dysfunction to multi-step leukemogenesis.

Shimizu R, Yamamoto M.

Cancer Sci. 2012 Dec;103(12):2039-44. doi: 10.1111/cas.12007. Epub 2012 Oct 10. Review.

17.

Tetrasomy 21 transient leukemia with a GATA1 mutation in a phenotypically normal trisomy 21 mosaic infant: case report and review of the literature.

Sandoval C, Pine SR, Guo Q, Sastry S, Stewart J, Kronn D, Jayabose S.

Pediatr Blood Cancer. 2005 Jan;44(1):85-91. Review.

PMID:
15390279
18.

A neonate with a unique non-Down syndrome transient proliferative megakaryoblastic disease.

Bertrums EJ, Buijs A, van Grotel M, Dors N, de Rooij JD, de Haas V, Hopman S, Jongmans MC, Zwaan CM, van den Heuvel-Eibrink MM.

Pediatr Blood Cancer. 2017 Mar;64(3). doi: 10.1002/pbc.26230. Epub 2016 Sep 26.

PMID:
27667142
19.

Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1.

Li Z, Godinho FJ, Klusmann JH, Garriga-Canut M, Yu C, Orkin SH.

Nat Genet. 2005 Jun;37(6):613-9. Epub 2005 May 15.

PMID:
15895080
20.

A novel mutation in the GATA1 gene associated with acute megakaryoblastic leukemia in a Korean Down syndrome patient.

Kim IS, Park ES, Lim JY, Ki CS, Chi HS.

J Korean Med Sci. 2008 Dec;23(6):1105-8. doi: 10.3346/jkms.2008.23.6.1105. Epub 2008 Dec 24.

Supplemental Content

Support Center